Gopalan Sethuraman

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +17

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

David Neal Franz, Jennifer Leonard, Cynthia Tudor et al. · Annals of Neurology · 2006 · 615 citations

Medicine, Neurology, Pathology +16

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 365 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis

David Neal Franz, Alan S. Brody, Cristopher A. Meyer et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 285 citations

Medicine, Pathology, Radiology +15

Safety and biomarker effects of solanezumab in patients with Alzheimer's disease

Martin R. Farlow, Steven E. Arnold, Christopher H. van Dyck et al. · Alzheimer s & Dementia · 2012 · 275 citations

Medicine, Neurology, Pharmacology +17